Search

Your search keyword '"Ear, Middle metabolism"' showing total 533 results

Search Constraints

Start Over You searched for: Descriptor "Ear, Middle metabolism" Remove constraint Descriptor: "Ear, Middle metabolism"
533 results on '"Ear, Middle metabolism"'

Search Results

1. Deciphering the mechanisms of the IL-6/CXCL1 and NOD-like receptor signaling pathways in otitis media with effusion in rodents.

2. Genome-wide association study indicates novel associations of annexin A13 to secretory and GAS2L2 with mucous otitis media.

3. Micro RNAs and Circular RNAs in Different Forms of Otitis Media.

4. Review of potential medical treatments for middle ear cholesteatoma.

5. Middle Ear "Adenoma": a Neuroendocrine Tumor with Predominant L Cell Differentiation.

6. Single-Cell Transcriptome Profiling Identifies Phagocytosis-Related Dual-Feature Cells in A Model of Acute Otitis Media in Rats.

7. Glycolytic Metabolism Is Critical for the Innate Antibacterial Defense in Acute Streptococcus pneumoniae Otitis Media.

8. The transcriptional landscape of the cultured murine middle ear epithelium in vitro.

9. Social buffering of cortisol release and tympanic temperature asymmetries during novelty and isolation stress in marmoset monkeys.

10. Suppression of lncRNA MALAT1 Reduces LPS- or IL-17A-Induced Inflammatory Response in Human Middle Ear Epithelial Cells via the NF- κ B Signaling Pathway.

11. miR-210 regulates the inflammation of otitis media with effusion by inhibiting the expression of hypoxia-inducible factor (HIF)-1a.

12. The Possible Role of Sclerostin in the Pathogenesis of Tympanosclerosis.

13. Uncovering the secreted signals and transcription factors regulating the development of mammalian middle ear ossicles.

14. Transcriptomic analysis of tobacco-flavored E-cigarette and menthol-flavored E-cigarette exposure in the human middle ear.

15. Multi-omic studies on missense PLG variants in families with otitis media.

16. Periostin in middle ear mucosa according to eosinophilic otitis media severity: Middle ear pathology-based treatment.

17. Panel 2- recent advance in otitis media bioinformatics.

18. Keratinocyte growth factor (KGF) induces stem/progenitor cell growth in middle ear mucosa.

19. [The research progress of keratin's roles in the pathology of middle ear cholesteatoma].

20. Innate immunity of surfactant protein A in experimental otitis media.

21. The Ca V 1.2 L-type calcium channel regulates bone homeostasis in the middle and inner ear.

22. Expression of endoplasmic reticulum stress-related mRNA in otitis media with effusion.

23. Role of ectodysplasin signalling in middle ear and nasal pathology in rat and mouse models of hypohidrotic ectodermal dysplasia.

24. Chronic otitis media is initiated by a bulla cavitation defect in the FBXO11 mouse model.

25. Genetic variation in thyroid folliculogenesis influences susceptibility to hypothyroidism-induced hearing impairment.

26. Expression of Endoplasmic Reticulum Stress-Related mRNAs in Chronic Otitis Media.

27. A requirement for Fgfr2 in middle ear development.

28. Treatment of Streptococcus pneumoniae otitis media in a chinchilla model by transtympanic delivery of antibiotics.

29. Water protection after tympanostomy (Shepard) tubes does not decrease otorrhea incidence - retrospective cohort study.

30. Stem cells in middle ear cholesteatoma contribute to its pathogenesis.

31. Expression, Distribution, and Role of C-Type Lectin Receptors in the Human and Animal Middle Ear and Eustachian Tube: A Review.

32. Loss of the homeostatic protein BPIFA1, leads to exacerbation of otitis media severity in the Junbo mouse model.

33. Mapping the distribution of stem/progenitor cells across the mouse middle ear during homeostasis and inflammation.

34. A Review: Expression of Aquaporins in Otitis Media.

35. Possible role of Dickkopf-1 protein in the pathogenesis of tympanosclerosis in a rat model.

36. Expression of calcium-binding proteins S100A8, S100A9 and S100A12 in otitis media.

37. A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways.

38. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.

39. High-mobility group box protein 1 expression in inflammatory diseases of the middle ear.

40. Immunohistological analysis of eotaxin and RANTES in the model animal of eosinophilic otitis media.

41. Bacterial Species and Antibiotic Sensitivity in Korean Patients Diagnosed with Acute Otitis Media and Otitis Media with Effusion.

42. Histamine Applied Topically to the Nasal Mucosa Increases the Transmucosal Nitrous Oxide Exchange for the Middle Ear.

43. Non-Typeable Haemophilus influenzae Infection of the Junbo Mouse.

44. Temporal and spatial expression patterns of Hedgehog receptors in the developing inner and middle ear.

45. Identification of Potential Novel Biomarkers and Signaling Pathways Related to Otitis Media Induced by Diesel Exhaust Particles Using Transcriptomic Analysis in an In Vivo System.

46. Differences in innate immune response gene regulation in the middle ear of children who are otitis prone and in those not otitis prone.

47. Eustachian Tube Function.

48. Expression of macrophage migration inhibitory factor and CD74 in the inner ear and middle ear in lipopolysaccharide-induced otitis media.

49. [The expression and significance of DDR2 and MMP-13in human middle ear cholesteatoma].

50. [Expression and significance of PDK1 and NF-κB in the middle ear cholesteatoma].

Catalog

Books, media, physical & digital resources